Ivanti’s Neurons platform focuses on the self-healing autonomous edge
As the fundamental units of the brain and nervous system, neurons play an important role in automatically relaying the electrical signals that control the human body. So, when Ivanti Inc. was looking to brand its latest hyper-automation platform, Neurons was a top choice.
“The market is demanding hyper-automation; it’s demanding more agnostic deployment; it needs more flexibility,” said Jeff Abbott (pictured, left), president of Ivanti. “Like the neurons in your brain, there will be a lot of superfast automation, superfast sensing of challenges. We really believe Neurons will connect with our target market.”
Abbott spoke with Lisa Martin, host of theCUBE, SiliconANGLE Media’s livestreaming studio. He was joined by Nayaki Nayyar (pictured, right), executive vice president and chief product officer at Ivanti, and they discussed how the company’s latest platform enables self-healing of devices at the edge and application of the technology for the healthcare industry. (* Disclosure below.)
Full stack hyper-automation
Tuesday’s unveiling of Ivanti Neurons marked an important step for the company, which specializes in the automation of information technology and security operations to discover, manage, secure and service devices from cloud to edge. The new platform is designed to proactively self-heal and self-secure devices using automation bots to detect and resolve issues.
“We’re taking hyper-automation and embedding that into our entire stack,” Nayyar said. “One of the key strengths Ivanti has is its ability to discover, secure, manage and service the endpoints. We want to get into a world of the self-healing autonomous edge.”
Ivanti’s foray into the self-healing autonomous edge has practical application in a number of industries, including healthcare. In addition to giving IT the ability to query edge devices, Neurons can allow first-line analysts to resolve issues quickly, which makes a difference in situations affecting patient health.
“IT challenges down at the device level in the healthcare industry can be life critical,” Abbott said. “They need to solve those IT challenges very fast. Neurons is absolutely what the healthcare industry is asking for.”
Watch the complete video interview below, and be sure to check out more of SiliconANGLE’s and theCUBE’s CUBE Conversations. (* Disclosure: Ivanti Inc. sponsored this segment of theCUBE. Neither Ivanti nor other sponsors have editorial control over content on theCUBE or SiliconANGLE.)
Since you’re here …
Show your support for our mission with our one-click subscription to our YouTube channel (below). The more subscribers we have, the more YouTube will suggest relevant enterprise and emerging technology content to you. Thanks!
Support our mission: >>>>>> SUBSCRIBE NOW >>>>>> to our YouTube channel.
… We’d also like to tell you about our mission and how you can help us fulfill it. SiliconANGLE Media Inc.’s business model is based on the intrinsic value of the content, not advertising. Unlike many online publications, we don’t have a paywall or run banner advertising, because we want to keep our journalism open, without influence or the need to chase traffic.The journalism, reporting and commentary on SiliconANGLE — along with live, unscripted video from our Silicon Valley studio and globe-trotting video teams at theCUBE — take a lot of hard work, time and money. Keeping the quality high requires the support of sponsors who are aligned with our vision of ad-free journalism content.